RE:BTD application7 out of 7 newly treated patients seem to be CR at 90 days. In August 19 out of 38 evaluable patients were CR. Today 26 out of 43 evaluable patients are CR. Awesome improvements.IMO
Aug 38 evaluable patients:
19 CR patients = 50% CR.
6 PR patients = 16 % CR
Total =66% responders
Nov. 43 evaluable patients
26 CR patients = 60.4%
7 PR patients = 16.3%
Total responders = 77%
If we disgard 5 patients who were severely undertreated and dropped out of trial early before 2nd treatment , plus patient who died of unrelated Heart failure, then we could count 6 patients less. ( that would still leave us with 7 undertreated patients in our data, but more realistic). That would be 26 CR out of 37, or 70.3% CR at 90 days, plus 7 out of 37, or 19% PR. For a realistic total responders at 89.2%. ( includes 7 undertreated patients). Total responders 26+7= 33 patients out of 37. I'm speculating on what our data could look like without initial 12 undertreated patents. Let's get AA in 2023 please. All IMHO